Featured Research

from universities, journals, and other organizations

Use of local anesthetics in the treatment of inflammatory bowel disease

Date:
July 7, 2010
Source:
World Journal of Gastroenterology
Summary:
Inflammatory bowel disease (IBD) is a chronic disease of the intestines and no definitive medical treatment has been defined yet. A research team from Turkey applied local anesthetics onto the experimentally induced colitis areas in rats to investigate their potential effect on treating the inflammation at the disease site. The improvement in the macroscopic inflammation at the site of application suggested that local anesthetics might have beneficial therapeutic effects on IBD.

Inflammatory bowel disease (IBD) is a disease of the gastrointestinal tract, mainly the intestines that may occur in the people who have genetic potential with a contribution of environmental factors. There has been no definitive medical treatment and drugs usually help the symptoms just to relieve.

Local anesthetics are used to locally desensitize the tissues to allow surgical interventions. However, their mechanism of action is based on their potential to inhibit neuronal activity in the area. Since it is proposed that IBD may be a result of imbalance in the autonomic neurons of the colon, local anesthetics have the potential to reduce the inflammation at the site of the colon that are affected by IBD.

A research article to be published on May 28, 2010 in the World Journal of Gastroenterology addresses this question. In a recent experimental study, investigators from Uludag University School of Medicine, Bursa, Turkey investigated the possible therapeutic effects of local anesthetics on IBD. They topically applied levobupivacaine, which is a novel, long lasting local anesthetic with less systemic side effects onto the colonic mucosa of the rats that had had experimentally induced IBD.

The researchers used some scoring systems that evaluated the inflammation at the site of drug application. They compared the local anesthetics to saline solution. They found some improvement in the degree of macroscopic inflammation at the areas where local anesthetics were applied; however, those findings were not supported by microscopic findings. Nevertheless, researchers concluded that local anesthetics might have potential therapeutic effects on IBD based on their findings.


Story Source:

The above story is based on materials provided by World Journal of Gastroenterology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Duman U, Yilmazlar A, Ozturk E, Aker S, Sarandol E, Yilmazlar T. Anti-inflammatory efficiency of levobupivacaine in an experimental colitis model. World Journal of Gastroenterology, 2010; 16 (20): 2537 DOI: 10.3748/wjg.v16.i20.2537

Cite This Page:

World Journal of Gastroenterology. "Use of local anesthetics in the treatment of inflammatory bowel disease." ScienceDaily. ScienceDaily, 7 July 2010. <www.sciencedaily.com/releases/2010/07/100707093849.htm>.
World Journal of Gastroenterology. (2010, July 7). Use of local anesthetics in the treatment of inflammatory bowel disease. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/07/100707093849.htm
World Journal of Gastroenterology. "Use of local anesthetics in the treatment of inflammatory bowel disease." ScienceDaily. www.sciencedaily.com/releases/2010/07/100707093849.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins